Mintz Levin is proud to host a five-part webinar series covering the Intellectual Property, Health Regulatory, FDA, Patent Litigation, Transactional, and Products Liability issues facing researchers, manufacturers, and distributors of biologics-based therapeutics. Mintz Levin is one of the few firms with the comprehensive cross-practice knowledge and experience to handle all of these issues, and we look forward to introducing that capability to you and discussing the rapidly evolving biologics/biosimilars landscape.

In this fourth installment of our biologics/biosimilars series, we'll discuss transactions and patent portfolios in the biologics/biosimilars space.